Patented Medicine Prices Review Board

The Patented Medicine Prices Review Board is a government agency in Canada which regulates drugs that are still under patent and which yet have no generic substitutes.

This Board establishes the maximum prices that can be charged in Canada for patented drugs.[1]

References

  1. ↑ AARP International: Prescription Drug Prices in Canada: What Are the Lessons for the U.S.?
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.